Until a vaccine is widely available, face masks and other nonpharmaceutical interventions (NPIs) will continue to be the frontline defense against Covid-19 in developing countries. But their effectiveness depends critically on compliance by young adults, who are most likely both to become...

This study seeks to provide evidence for deciding whether or not a pharmaceutical innovation should be included in the benefit list of social health insurance. A discrete choice experiment (DCE) was conducted in Germany to measure preferences for modern insulin therapy. Of the 1,100 individuals...

This study analyzes mobility patterns during the COVID-19 pandemic for eight large Latin American cities. Indicators of mobility by socioeconomic status (SES) are generated by combining georeferenced mobile phone information with granular census data. Before the pandemic, a strong positive...

Do individuals trust experts' advice? Does the sector represented by these experts matter for trust and compliance? Do individuals prefer the public or the private sector for large-scale responses to events such as the pandemic? We answer these questions by means of a large-scale survey on a...

Today, the global pharmaceutical product value chain is becoming increasingly complex and this has led to the emergence of 'multiple quality standards' for medicines. But this non-uniformity in the quality of medicine is also contingent upon both the regulatory milieu in the country of...